InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Nash Huw M., 首席运营官. Officer active across 1 company, notably Stoke Therapeutics, Inc.. Cumulatively, 12 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €30k. Activity tracked since 1 June 2021. The latest transaction was filed on 2 July 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Nash Huw M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,467 股@ US$13.10114.7% 占其流量Common StockSEC:0001415889-24-019169:0
50,000 股@ US$0.409.0% 占其流量Common StockSEC:0001415889-24-014093:0
50,000 股@ US$0.409.1% 占其流量Common StockSEC:0001415889-24-009993:0
13,100 股0Common StockSEC:0001415889-24-008686:0
3,800 股@ US$2.195.4% 占其流量Common StockSEC:0001209191-22-001849:0
5,700 股@ US$2.198.1% 占其流量Common StockSEC:0001209191-21-067950:0
3,800 股@ US$2.195.3% 占其流量Common StockSEC:0001209191-21-062772:0
5,700 股@ US$2.197.9% 占其流量Common StockSEC:0001209191-21-059111:0
5,700 股@ US$2.197.7% 占其流量Common StockSEC:0001209191-21-054552:0
5,700 股@ US$2.197.7% 占其流量Common StockSEC:0001209191-21-049793:0
5,700 股@ US$2.197.7% 占其流量Common StockSEC:0001209191-21-045097:0
575 股@ US$2.190.8% 占其流量Common StockSEC:0001209191-21-037839:0
12 条申报中的 12 条
About Nash Huw M.
Nash Huw M. is Chief Operating Officer and Chief Commercial Officer. He has 12 filings in total, and among the sampled recent filings from 2021-06-03 to 2024-07-03, sales total EUR 30070 and the most frequent transaction type is Option exercise. His filings concern Stoke Therapeutics, Inc., where he is Chief Business Officer.
